Money Makers Mentor

Prelude Therapeutics Files for Its IPO

Prelude Therapeutics Incorporated files for its IPO. According to the S-1 filing, the IPO will see the company trade shares on the NASDAQ at a yet to be announced date with the ticker symbol PRLD. As of right now, there is no word as to the number of shares or what price they will be. Prelude Therapeutics IPO has a proposed maximum aggregate offering price of $100 million. This figure includes the offering price of the shares that the underwriters have the choice to buy. Also, Morgan Stanley & Co. LLC, Goldman Sachs & Co. LLC, and BofA Securities, Inc serve as underwriters as Prelude Therapeutics files for its IPO. As of yet, there is no word as to the underwriter discounts or commissions.

However, there is word as to the use of proceeds from the IPO. Some of the money will go …

Leave A Reply

Your email address will not be published.